PMID: 8594243Feb 28, 1996Paper

Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study

JAMA : the Journal of the American Medical Association
C H HennekensJ E Buring

Abstract

To evaluate the association of breast implants with connective-tissue diseases. Retrospective cohort study of 395,543 female health professionals who completed mailed questionnaires for potential participation in the Women's Health Study. A total of 10,830 women reported breast implants and 11,805 reported connective-tissue diseases between 1962 and 1991. Cox proportional hazards regression models were used in analyses. Self-reported connective-tissue diseases. Compared with women who did not report breast implants, the relative risk (RR) of the combined end point of any connective-tissue disease among those who reported breast implants was 1.24 (95% confidence interval, 1.08 to 1.41, P = .0015). With respect to the individual diseases, the finding for other connective-tissue diseases (including mixed) was statistically significant (P = .017), the findings for rheumatoid arthritis, Sjogren's syndrome, dermatomyositis or polymyositis, or scleroderma were of borderline statistical significance (.05 < P < .10), and the finding for systemic lupus erythematosus was not statistically significant (P = .44). There were no clear trends in RR with increasing duration of breast implants. These self-reported data from female health profess...Continue Reading

Citations

Jul 20, 2002·Current Rheumatology Reports·S Lori BrownGene Pennello
Mar 4, 2011·Seminars in Immunopathology·Loren LipworthJoseph K McLaughlin
Aug 14, 1998·American Journal of Public Health·N Jacobson
Jul 27, 1999·Annals of the Rheumatic Diseases·C J SchaeferP H Wooley
Sep 30, 1999·Environmental Health Perspectives·M D Mayes
Jun 19, 2001·Annals of the Rheumatic Diseases·D M Dush
Oct 15, 2010·International Journal of Epidemiology·I-Min LeeJulie E Buring
Mar 16, 2000·Journal of Women's Health & Gender-based Medicine·K M RexrodeJ E Buring
Aug 2, 2001·Internal Medicine Journal·H EnglertL March
Mar 6, 1997·The New England Journal of Medicine·S J Mathes
Mar 16, 2000·The New England Journal of Medicine·E C JanowskyB S Hulka
Jul 28, 2007·Inflammopharmacology·A L Parke, W W Buchanan
Oct 28, 1999·Journal of Health & Social Policy·H A Palley, M L Palley
Apr 6, 2013·Expert Review of Clinical Immunology·Olga Vera-LastraYehuda Shoenfeld
Feb 7, 2001·Cancer Investigation·G Solomon
Feb 11, 2004·The American Journal of the Medical Sciences·Massimo MontaltoGiovanni Gasbarrini
Aug 17, 2010·Journal of Autoimmunity·Yehuda Shoenfeld, Nancy Agmon-Levin
May 13, 1999·The American Journal of Medicine·E W KarlsonP H Schur
Dec 22, 2004·Internal Medicine Journal·H EnglertL March
Mar 17, 2007·Risk Analysis : an Official Publication of the Society for Risk Analysis·Steffen Foss HansenJoel A Tickner
Oct 1, 2010·European Journal of Clinical Investigation·Steven D HajduYehuda Shoenfeld
Nov 1, 1996·Rheumatic Diseases Clinics of North America·A J Silman, M C Hochberg
Oct 19, 2004·Rheumatic Diseases Clinics of North America·Hyon K Choi, Gary Curhan
May 7, 2013·Seminars in Arthritis and Rheumatism·Jaume Alijotas-ReigLluís Puig
Feb 1, 2005·The Lancet Infectious Diseases·Brigitte PittetDidier Pittet
Oct 18, 2018·International Journal of Epidemiology·Abdulla WatadHoward Amital
Jun 20, 2002·Epidemiology·S Lori Brown
Sep 12, 2002·Reviews on Environmental Health·D Radford Shanklin, D L Smalley
May 5, 2001·Epidemiology·L A BrintonR N Hoover
Nov 20, 2002·Clinical Obstetrics and Gynecology·Mindy Smith, Karen Kent
Apr 6, 2000·Current Opinion in Rheumatology·T McAlindon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.